JamesPOhrDO

Oncology • Erie, PA

Physician

Join to view full profile

Dr. Ohr is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ohr's full profile

Already have an account?

Office
2500 W 12th St
Erie, PA 16505
Phone+1 814-836-2600

Fax+1 412-235-1030

Education & Training

Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2005 - 2008
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2000 - 2003
Philadelphia College of Osteopathic MedicineClass of 2000

Certifications & Licensure

NY State License 2020 - 2026
PA State License 2001 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013

Clinical Trials

Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation Start of enrollment: 2013 Jun 07
Terminated
Phase 2
Radiosurgery for Patients Recurrent Oligometastatic Disease Start of enrollment: 2011 Jun 28
Completed
Not Applicable
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN Start of enrollment: 2013 Jul 03
Completed
Phase 2

Publications & Presentations

PubMed

4 citations
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer.
Julie E Bauman, Zhengjia Chen, Chao Zhang, James P Ohr, Robert L Ferris
Cancers. 2022-05-26
23 citations
Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinoma
William Greer Albergotti, Kara S. Davis, Shira Abberbock, Julie E. Bauman, James Ohr
Oral Oncology. 2016-09-01
45 citations
Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
Diane C. Ling, John A. Vargo, Robert L. Ferris, James Ohr, David A. Clump
International Journal of Radiation Oncology, Biology, Physics. 2016-07-01